These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 32352250
1. Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children. Vittitow JL, Williams JI. J Cataract Refract Surg; 2020 Aug; 46(8):1092-1101. PubMed ID: 32352250 [Abstract] [Full Text] [Related]
2. Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery. Lane SS, Holland EJ. J Cataract Refract Surg; 2013 Feb; 39(2):168-73. PubMed ID: 23232255 [Abstract] [Full Text] [Related]
3. A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation. The Loteprednol Etabonate Postoperative Inflammation Study Group 2. Ophthalmology; 1998 Sep; 105(9):1780-6. PubMed ID: 9754192 [Abstract] [Full Text] [Related]
4. Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation. Loteprednol Etabonate Post-operative Inflammation Study Group 1. Stewart R, Horwitz B, Howes J, Novack GD, Hart K. J Cataract Refract Surg; 1998 Nov; 24(11):1480-9. PubMed ID: 9818338 [Abstract] [Full Text] [Related]
5. Submicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery. Fong R, Silverstein BE, Peace JH, Williams JI, Vittitow JL. J Cataract Refract Surg; 2018 Oct; 44(10):1220-1229. PubMed ID: 30193927 [Abstract] [Full Text] [Related]
6. Efficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgery. Rajpal RK, Roel L, Siou-Mermet R, Erb T. J Cataract Refract Surg; 2013 Feb; 39(2):158-67. PubMed ID: 23218817 [Abstract] [Full Text] [Related]
7. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study. Holzer MP, Solomon KD, Sandoval HP, Vroman DT. J Cataract Refract Surg; 2002 Jan; 28(1):93-9. PubMed ID: 11777716 [Abstract] [Full Text] [Related]
8. Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group. Am J Ophthalmol; 1999 May; 127(5):537-44. PubMed ID: 10334346 [Abstract] [Full Text] [Related]
9. Loteprednol etabonate ophthalmic gel 0.5% following cataract surgery: integrated analysis of two clinical studies. Rajpal RK, Fong R, Comstock TL. Adv Ther; 2013 Oct; 30(10):907-23. PubMed ID: 24136301 [Abstract] [Full Text] [Related]
10. Safety and tolerability of loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension in pediatric subjects. Comstock TL, Paterno MR, Bateman KM, Decory HH, Gearinger M. Paediatr Drugs; 2012 Apr 01; 14(2):119-30. PubMed ID: 22292487 [Abstract] [Full Text] [Related]
11. Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery. Comstock TL, Paterno MR, Singh A, Erb T, Davis E. Clin Ophthalmol; 2011 Apr 01; 5():177-86. PubMed ID: 21383946 [Abstract] [Full Text] [Related]
12. Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies. Fong R, Cavet ME, DeCory HH, Vittitow JL. Clin Ophthalmol; 2019 Apr 01; 13():1427-1438. PubMed ID: 31447544 [Abstract] [Full Text] [Related]
13. Comparison of Efficacy of Difluprednate 0.05% and Loteprednol Gel 0.5% After Cataract Surgery. Abessi B, Brooksby L, Schultze RL. Eye Contact Lens; 2018 Nov 01; 44 Suppl 2():S37-S42. PubMed ID: 28628490 [Abstract] [Full Text] [Related]
14. Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial. Fong R, Leitritz M, Siou-Mermet R, Erb T. Clin Ophthalmol; 2012 Nov 01; 6():1113-24. PubMed ID: 22888209 [Abstract] [Full Text] [Related]
15. Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty: Prospective Randomized Trial. Price MO, Feng MT, Scanameo A, Price FW. Cornea; 2015 Aug 01; 34(8):853-8. PubMed ID: 26020827 [Abstract] [Full Text] [Related]
16. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. Wilson ME, O'Halloran H, VanderVeen D, Roarty J, Plager DA, Markwardt K, Gedif K, Lambert SR. Eye (Lond); 2016 Sep 01; 30(9):1187-94. PubMed ID: 27367745 [Abstract] [Full Text] [Related]
18. Comparison of 2 regimens of loteprednol etabonate and bromfenac for cataract surgery. Al-Awadi A, Tokko HA, Chan CC, Somani S. Can J Ophthalmol; 2019 Jun 01; 54(3):388-394. PubMed ID: 31109481 [Abstract] [Full Text] [Related]
19. Loteprednol etabonate ophthalmic gel 0.5%: a review of its use in post-operative inflammation and pain following ocular surgery. Lyseng-Williamson KA. Drugs; 2013 Jun 01; 73(9):949-58. PubMed ID: 23740411 [Abstract] [Full Text] [Related]
20. Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Inflammation and Pain Following Ocular Surgery. Kang C, Keam SJ, Shirley M, Syed YY. Clin Drug Investig; 2020 Apr 01; 40(4):387-394. PubMed ID: 32172521 [Abstract] [Full Text] [Related] Page: [Next] [New Search]